Foresight Diagnostics
Lena Caron currently serves as the Associate Lab Director at Foresight Diagnostics since December 2024. Prior to this role, Lena worked as a Pathologist and Associate Medical Director at Foundation Medicine from September 2020 to December 2024. Earlier experience includes a position as Chief Resident and Resident Physician in Anatomic Pathology at Massachusetts General Hospital from July 2015 to September 2020, as well as a Hematopathology Fellowship. Educational background includes a Doctor of Medicine (MD) from The Johns Hopkins University School of Medicine and a Bachelor of Science (B.S.) in Biology, Chemistry, and Health Science from Guilford College. Lena also gained initial professional experience as a Data Analyst at gap intelligence from January 2008 to June 2009.
This person is not in any teams
This person is not in any offices
Foresight Diagnostics
1 followers
Foresight Diagnostics is the world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.